期刊
NEUROPSYCHOPHARMACOLOGY
卷 36, 期 8, 页码 1620-1630出版社
SPRINGERNATURE
DOI: 10.1038/npp.2011.43
关键词
CB1 receptor; paranoid schizophrenia; post-mortem; autoradiography; real time PCR
资金
- Schizophrenia Research Institute
- New South Wales Health
- Macquarie Group Foundation
- Neuroscience Research Australia
- University of New South Wales
- National Health and Medical Research Council of Australia
- National Institute of Alcohol Abuse and Alcoholism (NIH (NIAAA)) [R24AA012725]
A number of studies suggest a dysregulation of the endogenous cannabinoid system in schizophrenia (SCZ). In the present study, we examined cannabinoid CB1 receptor (CB1R) binding and mRNA expression in the dorsolateral prefrontal cortex (DLPFC) (Brodmann's area 46) of SCZ patients and controls, post-mortem. Receptor density was investigated using autoradiography with the CB1R ligand [H-3] CP 55 940 and CB1R mRNA expression was measured using quantitative RT-PCR in a cohort of 16 patients with paranoid SCZ, 21 patients with non-paranoid SCZ and 37 controls matched for age, post-mortem interval and pH. All cases were obtained from the University of Sydney Tissue Resource Centre. Results were analyzed using one-way analysis of variance (ANOVA) and post hoc Bonferroni tests and with analysis of covariance (ANCOVA) to control for demographic factors that would potentially influence CB1R expression. There was a main effect of diagnosis on [H-3] CP 55 940 binding quantified across all layers of the DLPFC (F(2,71) = 3.740, p = 0.029). Post hoc tests indicated that this main effect was due to patients with paranoid SCZ having 22% higher levels of CB1R binding compared with the control group. When ANCOVA was employed, this effect was strengthened (F(2,67) = 6.048, p = 0.004) with paranoid SCZ patients differing significantly from the control (p = 0.004) and from the non-paranoid group (p = 0.016). In contrast, no significant differences were observed in mRNA expression between the different disease subtypes and the control group. Our findings confirm the existence of a CB1R dysregulation in SCZ and underline the need for further investigation of the role of this receptor particularly in those diagnosed with paranoid SCZ. Neuropsychopharmacology (2011) 36, 1620-1630; doi:10.1038/npp.2011.43; published online 6 April 2011
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据